MCC14/2Homo sapiens (Human)Cancer cell line

Also known as: MCC142, MCC14/2 TC, MCC14/2TC, MCC14-2

🤖 AI SummaryBased on 5 publications

Quick Overview

MCC14/2 is a human Merkel cell carcinoma cell line used in cancer research.

Detailed Summary

MCC14/2 is a human cell line derived from Merkel cell carcinoma (MCC), a rare and aggressive form of skin cancer. It is one of several MCC cell lines established for research purposes, including studies on genetic mutations, neuroendocrine markers, and tumor biology. The cell line is characterized by its adherence to culture surfaces and its expression of certain neuroendocrine markers, though it lacks some features seen in other MCC lines. Research on MCC14/2 has contributed to understanding the molecular mechanisms of MCC, including the role of transcription factors like Brn-3c and HATH1, and the potential involvement of genes such as CDKN2A and TP53 in tumorigenesis. The cell line is used in studies related to neuroendocrine differentiation, tumor progression, and therapeutic strategies for MCC.

Research Applications

Cancer researchNeuroendocrine differentiationGenetic mutation analysisTumor biologyTherapeutic strategies

Key Characteristics

Adherent cell lineExpresses neuroendocrine markersInvolvement in CDKN2A and TP53 studiesExpression of Brn-3c and HATH1
Generated on 6/19/2025

Basic Information

Database IDCVCL_2584
SpeciesHomo sapiens (Human)
Tissue SourceIliac lymph node[UBERON:UBERON_0015878]

Donor Information

Age80
Age CategoryAdult
SexMale

Disease Information

DiseaseCutaneous neuroendocrine carcinoma
LineageSkin
SubtypeMerkel Cell Carcinoma
OncoTree CodeMCC

DepMap Information

Source TypeSigma-Aldrich
Source IDACH-001551_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Val272Glu (c.815T>A)Unspecified-Unknown, PubMed=10732753

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
13
D16S539
13
D18S51
12,15,17
D19S433
12,14
D21S11
29,32.2
D2S1338
19
D3S1358
16
D5S818
13
D7S820
8,10
D8S1179
10,14
FGA
21
Penta D
9,12
Penta E
7
TH01
6,9.3
TPOX
8
vWA
17,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma.

Speleman F., Sturm R.A.

Int. J. Cancer 101:103-110(2002).

CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin.

Baumann K.C., Hayward N.K., Leonard J.H.

Int. J. Cancer 93:361-367(2001).

Mutation analysis of P73 and TP53 in Merkel cell carcinoma.";

De Wolf-Peeters C., De Paepe A., Caput D., Speleman F.

Br. J. Cancer 82:823-826(2000).

A nonconsensus octamer-recognition sequence (TAATGARAT-motif) identifies a novel DNA binding protein in human Merkel cell carcinoma cell lines.

Thomson J.A.F., Leonard J.H., McGregor K., Sturm R.A., Parsons P.G.

Int. J. Cancer 58:285-290(1994).

Characterisation of four Merkel cell carcinoma adherent cell lines.";

Leonard J.H., Dash P., Holland P., Kearsley J.H., Bell J.R.

Int. J. Cancer 60:100-107(1995).